University of Aberdeen logo

AURA - Aberdeen University Research Archive

 

Oral corticosteroid (OCS) risk predictor for Type II Diabetes in asthma

Citation

Stanley, B, Menzies-Gow, A, Bourdin, A, Canonica, G W, Gurnell, M, Reddel, H K, Heaney, L G, Carter, V, Chapaner, J, Tran, T N, Maslova, E, Maslova, E & Price, D 2022, 'Oral corticosteroid (OCS) risk predictor for Type II Diabetes in asthma', European Respiratory Society (ERS) International Congress., Barcelona, Spain, 4/09/22 - 6/09/22.
conference

DOI

Collections

Endorsement

Review

Supplemented By

Referenced By